[Cross-over trial with Peripress (prazosin) and Apresolin (hydralazin), both in combination with beta-blocker].
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003430:Cross-Sectional Studies; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011224:Prazosin / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*; D011674:Pulse / Q000187:drug effects; D011799:Quinazolines / Q000627:therapeutic use*
D011799:Quinazolines; D006830:Hydralazine; D011433:Propranolol; D011224:Prazosin
Undersøkelse av Peripress (prazosin) i kryssbytte med Apresolin (hydralazin) i kombinasjon med beta-blokker.